Novartis Ducks More Damages In Whistleblower Suit

Law360, Morristown, N.J. (February 27, 2019, 4:28 PM EST) -- Novartis Pharmaceuticals Corp. escaped a punitive damages verdict Wednesday in a New Jersey state trial over a former company executive’s claims she was fired in retaliation for objecting to a proposed drug study, a day after the pharmaceutical giant was slapped with nearly $1.5 million in net compensatory damages.

After less than an hour of deliberations, eight jurors in a 7-1 vote decided against awarding such damages after finding that Novartis upper management did not engage in “especially egregious” conduct in connection with Min Amy Guo's termination for allegedly raising concerns about the potential study of cancer drug Afinitor by pharmaceutical...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!